Alnylam Pharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ALNY Nasdaq 2836 www.alnylam.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alnylam Pharmaceuticals, Inc.

Got $5,000? 3 Top Growth Stocks to Buy That Could Double Your Money - Nov 11th, 2025 3:40 am
New Post Hoc Analysis from the HELIOS-B Phase 3 Study Shows Vutrisiran Improved Measures of Heart Structure and Function in Patients with ATTR-CM - Nov 8th, 2025 2:57 pm
A Closer Look at Alnylam Pharmaceuticals (ALNY) Valuation Following Improved Earnings and Raised Revenue Guidance - Nov 7th, 2025 9:25 pm
Sector Update: Health Care Stocks Rise Late Afternoon - Nov 4th, 2025 1:59 pm
Top 20 biopharma companies Q3 2025 market cap up 4% despite headwinds - Nov 4th, 2025 9:28 am
Alnylam to Webcast Presentations at Upcoming November Investor Conferences - Nov 4th, 2025 6:00 am
Royalty Pharma Acquires Royalty Interest in Alnylam’s AMVUTTRA for $310 Million from Blackstone Life Sciences - Nov 4th, 2025 5:15 am
Coca-Cola Upgraded, Boeing Downgraded: Updated Rankings on Top Blue-Chip Stocks - Nov 3rd, 2025 7:56 am
Alnylam Pharmaceuticals, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year - Nov 2nd, 2025 7:01 am
How Alnylam's Raised 2025 Revenue Outlook and AMVUTTRA Uptake Will Impact ALNY Investors - Nov 1st, 2025 2:15 am
ALNY Q3 Earnings and Revenues Top Estimates on Higher Amvuttra Sales - Oct 31st, 2025 8:37 am
Alnylam Pharmaceuticals Inc (ALNY) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... - Oct 30th, 2025 2:24 pm
Alnylam Stock Has Almost Doubled In 2025. But It Took A Hit On Earnings. - Oct 30th, 2025 2:15 pm
Earnings roundup: Alnylam’s down day, Neurocrine’s head scratch and Biogen’s ‘low quality’ win - Oct 30th, 2025 11:13 am
Compared to Estimates, Alnylam (ALNY) Q3 Earnings: A Look at Key Metrics - Oct 30th, 2025 8:30 am
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick - Oct 30th, 2025 7:50 am
Alnylam Pharmaceuticals (ALNY) Q3 Earnings and Revenues Top Estimates - Oct 30th, 2025 7:15 am
Alnylam: Q3 Earnings Snapshot - Oct 30th, 2025 6:16 am
Alnylam Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Period Progress - Oct 30th, 2025 6:00 am
Amgen's Q3 Earnings in the Cards: Here's What to Expect - Oct 29th, 2025 9:27 am